Approved Study Database

Ref. No. Scientific Title Principal investigator
2014.509 Evaluation of Anti-Mullerian Hormone as a predictive market in ovarian reserve and assisted reproductive technology Prof. KONG Grace Wing Shan
2014.573 Additional information from array comparative genomic hybridization technology over conventional karyotyping on diagnosing genetic cause of women with recurrent miscarriage Dr. KONG Grace Wing Shan
2008.287 The Physical and Psychological Outcomes of Expectant Management, Surgical Evacuation or Medical Evacuation with Single Dose 800 mcg Vaginal Misoprostol for Women with First Trimester Miscarriage in a Randomized Controlled Trial Dr Kong Grace Wing Shan
2013.533 A pilot study of thrombophilia among Chinese women with Recurrent miscarriage Prof. KONG Grace Wing Shan
2012.440 The habit and perception of using bicycle helmet and protective gear in Hong Kong cyclist Miss Kong Chung Yan
2010.429 A randomized trial of carbetocin versus syntocinon in the management of third stage of labour in low risk group of caesarean sections and in 3 high risk groups of caesarean sections: multiple, pregnancies, placenta praevia and uterine fibroid greater than 5 cm. Dr. Kong Choi Wah
2007.492 Hip Bone Mineral Density in Post-Menopausal Women with Regular Swimming Doctor Kong Chi Keung
2023.179 Periprosthetic Joint Infection following hip and knee arthroplasties in Hong Kong Dr. KONG Cheryl Cheuk Wing
2024.226 Clinical outcome of using volar plating in proximal phalangeal base fracture Dr. KONG Cheryl Cheuk Wing
2006.136 Sleep Duration, Neurohormonal Dysregulation and Obesity in Hong Kong Children and Adolescents Prof. KONG Alice PS
2009.210 TECOS: A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes after Treatment with Sitagliptin in Patients with Type 2 Diabetes Mellitus and Inadequate Glycemic Control Dr Kong Alice Pik-Shan
2008.515 A Multi-center, Double-blind, Randomized, Parallel Group, Placebo-controlled 12-week Study to Investigate Glycemic Parameters of Efficacy, Safety/ Tolerability and Pharmacokinetics of Five Dose Levels of RO4998452 in Patients with Type 2 Diabetes Mellitus Professor Kong Alice Pik-Shan
2008.383 A Multi-Center, Randomized, Open-Label, Active-Controlled Study to Compare the Efficacy, Safety and Tolerability of Taspoglutide (RO5073031) versus Insulin Glargine in Insulin-Naive Type 2 Diabetic Patients Inadequately Controlled with Metformin and Sulphonylurea Combination Therapy Prof. Kong Alice Pik-Shan
2008.099 An Open-Label, Randomized, Multicenter, Parallel-group study to Demonstrate Correction of Anemia Using Once Every Four Weeks Subcutaneous Injections of RO0503821 in Patients with Chronic Kidney Disease Who are not on Dialysis Prof. Kong Alice Pik-Shan
2010.516 A randomized controlled trial to investigate the impact of sleep education program on glycemic control in Hong Kong Chinese type 2 diabetic patients. Prof. KONG Alice Pik Shan
2025.115 Continuous glucose monitoring in older adults with type 2 diabetes: A randomized controlled trial Prof. KONG Alice Pik Shan
2024.480 Dysregulated Host - Gut Microbiota Co-Metabolism in Metabolic dysfunction-associated steatotic liver disease (MASLD) Prof. KONG Alice Pik Shan
江碧珊
2011.131 In search of the missing heritability in complex diseases: whole transcriptome analysis of type diabetes using a strand-specific RNA-sequencing approach Prof. KONG Alice Pik Shan
2012.505 Gene-Environment Interactions in Childhood Obesity Prof Kong Alice Pik Shan
2012.506 A prospective follow-up study of sleep habits, obesity and obesity associated cardiovascular risk factors in Hong Kong Chinese school children Prof Kong Alice Pik Shan
2009.088 A Randomized Controlled Trial to Investigate the Impact of a Low Glycemic Index (GI) Diet on Body Mass Index and Obesity Related Cardiovascular and Hormonal Factors in Chinese Adolescents Prof Kong Alice Pik Shan
2010.246 Sleep Behaviour and Glycemic Control in Hong Kong Type 2 Diabetes Patients Prof. KONG Alice Pik Shan
2002.182 Diabetes Mellitus, Obesity and Cardiovascular Risk Factors in Hong Kong Adolescents Prof. KONG Alice Pik Shan
2009.272 Prevalence of melamine incident and follow-up studies in Hong Kong school children Prof Kong Alice Pik Shan
2013.113 Impact of Diet on Sleep Quantity and Quality of Obese Adolescents Prof Kong Alice Pik Shan
2011.492 Prevalence of Human Adenovirus-36 (Ad-36) Infection in Hong Kong Chinese School Children And Its Association with Obesity and Obesity Related Cardiometablic Risk Factors Prof. KONG Alice Pik Shan
2023.087 Using inflammatory markers and microRNA to identify obese individuals at risk of nonalcoholic steatohepatitis Prof. KONG Alice Pik Shan
2024.059 Elucidate the use of honokiol, an activator of sirtuin-3 (SIRT3), in the treatment of non-alcoholic fatty liver disease (NAFLD) Prof. KONG Alice Pik Shan
江碧珊
2021.266 The impact of cognitive behavioral therapy for insomnia (CBT-I) on glycemic control in older type 2 diabetes (T2D) comorbid with insomnia Prof. KONG Alice Pik Shan
江碧珊
2023.539 Metabolically healthy and unhealthy obese young individuals in Hong Kong: a prospective follow-up study Prof. KONG Alice Pik Shan
江碧珊
2017.201 Relationship between Environmental Pollutants and Depression in Patients with Type 2 Diabetes Prof. KONG Alice Pik Shan
江碧珊醫生
2015.406 A multi-center, double blind, randomized, placebo controlled study of Testogel® (testosterone gel 50mg/5g) in the treatment of male hypogonadism Prof. KONG Alice Pik Shan
2016.213 Early detection of liver cancer in type 2 diabetes using serum microRNA Prof. KONG Alice Pik Shan
江碧珊
2016.641 A Pragmatic Clinical Trial to Address the Knowledge Gaps and Unmet Needs in the Management of Patients with Type 2 Diabetes and Chronic Liver Disease Prof. KONG Alice Pik Shan
江碧珊醫生
2017.243 Association between branched-chain amino acids and renal function in Chinese type 2 diabetes patients with MTOR genetic variants Prof. KONG Alice Pik Shan
2020.557 A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis Prof. KONG Alice Pik Shan
2018.386 Clinical course and biomarkers associated with nonalcoholic fatty liver disease (NAFLD) in Chinese patients with obesity Prof. KONG Alice Pik Shan
江碧珊
2019.178 A prospective follow-up study of sleep habits, obesity and obesity associated cardiovascular risk factors in Hong Kong Chinese school children Prof. KONG Alice Pik Shan
江碧珊醫生
2018.263 Validation of liver cancer serum microRNA markers Prof. KONG Alice Pik Shan
江碧珊
2014.209 Anti-viral and anti-inflammatory role of Vitamin D in airway epithelia infected with human rhinovirus species C Prof Ko Wing hung
2017.086 Role of sphingosine 1-phosphate signaling in regulating electrolyte transport and P2Y receptor-mediated pro-inflammatory cellular response in human airway epithelia Prof. KO Wing hung
高永雄教授
2016.132 Role of sphingosine 1-phosphate signaling in regulating electrolyte transport and P2Y receptor-mediated pro-inflammatory cellular response in human airway epithelia Prof. KO Wing Hung
高永雄教授
2007.429 A Study of the Infectious Etiologies of Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease Dr Ko Wai-san Fanny
2008.442 A Comprehensive Care Programme for Patients with Chronic Obstructive Pulmonary Disease Dr. Ko Wai-san Fanny
2025.061 Pilot Observational Study of BioRNA Treatment of Keloid and hypertrophic burns scars Dr. KO Wai Shan
2015.544 The effects of Activskin on deep partial thickness burns: a randomized control trial Dr. KO Wai Shan
2016.455 The effects of Activskin on chronic ulcers: a pilot trial Dr. KO Wai Shan
2016.075 Evaluation of the efficacy and safety of combined application of CGPASTE and CuraVAC® on chronic wound Dr. KO Wai Shan
高慧珊
2015.164 Multiplex Molecular Detection of Respiratory Pathogens of adult patients admitted to hospital for exacerbation of asthma and chronic obstructive pulmonary disease and their clinical outcomes. Dr. KO Wai San
2018.477 Evaluation of pulmonary rehabilitation program for patients with chronic respiratory diseases other than COPD Mr. KO Wai Nam
高蔚南

Page 150 of 262.